Skip to Content

b 859 (Flecainide Acetate 50 mg)

Pill with imprint b 859 is White, Round and has been identified as Flecainide Acetate 50 mg. It is supplied by Teva Pharmaceuticals USA.

Flecainide is used in the treatment of atrial fibrillation; atrial flutter; ventricular tachycardia; supraventricular tachycardia; paroxysmal supraventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for b 859

Flecainide acetate 50 mg b 859
Flecainide acetate 50 mg b 859
Flecainide acetate 50 mg b 859

Flecainide Acetate

Imprint
b 859
Strength
50 mg
Color
White
Size
7.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00555-0859
Inactive Ingredients
silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, corn starch, sodium stearyl fumarate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "b 859"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.